A significant paradigm shift is underway in small-molecule drug discovery, as a pioneering collaboration between Ginkgo Datapoints, Tangible Scientific, and…
Read More
AI Reshapes Mass Spectrometry: James Campbell and Move Analytical Drive Innovation in Metabolomics
The landscape of analytical chemistry, particularly within mass spectrometry (MS), is undergoing a profound transformation driven by the integration of…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A significant shift is underway in the landscape of small-molecule drug discovery, as a new collaborative platform seeks to revolutionize…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
For decades, the pharmaceutical industry has grappled with the inherent inefficiencies of drug discovery, a process often likened to searching…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A significant paradigm shift is underway in the pharmaceutical industry’s approach to small-molecule drug discovery, as a new collaborative platform,…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A new collaborative platform, ADME-One, has been launched by Ginkgo Datapoints, Tangible Scientific, and Inductive Bio, signaling a significant shift…
Read More
Eli Lilly Acquires Ajax Therapeutics for Up to $2.3 Billion in Strategic Move to Bolster Oncology Pipeline
Eli Lilly and Company has significantly expanded its oncology portfolio with the definitive agreement to acquire Ajax Therapeutics, a clinical-stage…
Read More
MSD Acquires Terns Pharmaceuticals for $6.7 Billion in Strategic Move to Bolster Oncology Pipeline Ahead of Keytruda Patent Expiry
In a significant development poised to reshape the competitive landscape of cancer therapeutics, global pharmaceutical giant MSD (known as Merck…
Read MoreYOU MAY HAVE MISSED
